Uk Vaccine Trials
- All
- News
- Videos
-
Revolutionary Cancer Vaccine Doubles Survival Rates, Igniting New Hope
A promising new personalized mRNA vaccine for melanoma is being tested in Britain. This custom-made vaccine offers hope for a cure and is undergoing final stage trials at UCLH.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
G7 Health Ministers To Strengthen Cooperation Against Future Pandemics
The Group of Seven (G7) agreed on Friday to speed up cooperation on vaccine and therapeutic trials to tackle COVID-19 and future pandemics, the UK government has announced after hosting a two-day meeting of the bloc's health ministers at the Universi
-
Adar Poonawalla To Invest Over $300 Million In UK
Vaccine maker the Serum Institute of India is set to invest in facilities in the United Kingdom and could even manufacture inoculations in the UKin future, British Prime Minister Boris Johnson said Monday.
-
UK Experts Hail "Unprecedented" Results Of Malaria Vaccine In Serum Institute Tie-Up
An under-trial malaria vaccine was hailed as delivering "unprecedented efficacy levels" to achieve the WHO specified goal of 75 per cent efficacy and is now set to enter the next stage of trials, in collaboration with the Serum Institute of India.
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
-
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
-
In World First, Britain To Mix Pfizer And Oxford Vaccine Doses
British researchers are to explore mixing doses of the Pfizer and AstraZeneca COVID-19 vaccines in a world first trial aimed at finding new ways to swiftly reduce coronavirus infections as new mutated variants emerge.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
-
Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump
Serum Institute Of India has applied to conduct local trial for Novavax vaccine
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
"When Is India's Turn, Modi Ji?": Rahul Gandhi's Jibe Over Covid Vaccine
Congress's Rahul Gandhi today aimed a jibe at Prime Minister Narendra Modi, pointing to several nations beginning inoculation for Covid and implying India's journey towards a vaccine is slow. Four nations -- US, UK, China and Russia -- are pressing ahead with vaccination as a new, more infectious mutation of the virus has brought life to a standsti...
-
British Foreign Secretary Calls On PM Modi; Discusses Post-Brexit World
British Foreign Secretary Dominic Raab called on Prime Minister Narendra Modi on Wednesday and discussed the vast potential of the India-UK partnership in the post-Brexit world, and launching of a 'vaccines hub' which will share best practice for clinical trials and foster innovation besides helping in shared fight against coronavirus.
-
Revolutionary Cancer Vaccine Doubles Survival Rates, Igniting New Hope
A promising new personalized mRNA vaccine for melanoma is being tested in Britain. This custom-made vaccine offers hope for a cure and is undergoing final stage trials at UCLH.
-
Needle-Free Air-Powered Covid Vaccine Trial Begins In UK
Scientists at the University of Cambridge on Tuesday began a clinical trial of a needle-free air-powered vaccine, which is expected to help combat future variants of COVID-19.
-
G7 Health Ministers To Strengthen Cooperation Against Future Pandemics
The Group of Seven (G7) agreed on Friday to speed up cooperation on vaccine and therapeutic trials to tackle COVID-19 and future pandemics, the UK government has announced after hosting a two-day meeting of the bloc's health ministers at the Universi
-
Adar Poonawalla To Invest Over $300 Million In UK
Vaccine maker the Serum Institute of India is set to invest in facilities in the United Kingdom and could even manufacture inoculations in the UKin future, British Prime Minister Boris Johnson said Monday.
-
UK Experts Hail "Unprecedented" Results Of Malaria Vaccine In Serum Institute Tie-Up
An under-trial malaria vaccine was hailed as delivering "unprecedented efficacy levels" to achieve the WHO specified goal of 75 per cent efficacy and is now set to enter the next stage of trials, in collaboration with the Serum Institute of India.
-
AstraZeneca UK Vaccine Trial On Children Paused As Clot Link Probed
A British trial of the AstraZeneca coronavirus vaccine on children has been paused while regulators assess its possible link to blood clots, Oxford University, which helped develop the jab, said Tuesday.
-
Covaxin 81% Effective, Works Against UK Variant, Claims Bharat Biotech
Covaxin is 81 per cent effective in preventing Covid and can work against the UK variant of the virus, Bharat Biotech said Wednesday as it revealed a "first interim analysis" of Phase III trial results for a vaccine cleared in January amid concerns over safety and efficacy.
-
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
-
In World First, Britain To Mix Pfizer And Oxford Vaccine Doses
British researchers are to explore mixing doses of the Pfizer and AstraZeneca COVID-19 vaccines in a world first trial aimed at finding new ways to swiftly reduce coronavirus infections as new mutated variants emerge.
-
Oxford Kept UK Vaccine Volunteers In Dark On Dose Error: Report
About 1,500 of the initial volunteers in a late-stage clinical trial of the Oxford/AstraZeneca COVID-19 vaccine were given the wrong dose, but weren't informed that a mistake had been made after the blunder was discovered, documents obtained by Reuters show.
-
India Trial Sought for Novavax Covid Vaccine: 10 Facts
The Serum Institute of India, the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of American vaccine developer Novavax's COVID-19 jab, which was found to be 89.3 per cent effective in a UK trial. It was also found to be highly effective against a variant first identified in the UK. But the positive...
-
Novavax Claims Covid-19 Vaccine 89% Effective In UK Trial, Less In South Africa, Shares Jump
Serum Institute Of India has applied to conduct local trial for Novavax vaccine
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
"When Is India's Turn, Modi Ji?": Rahul Gandhi's Jibe Over Covid Vaccine
Congress's Rahul Gandhi today aimed a jibe at Prime Minister Narendra Modi, pointing to several nations beginning inoculation for Covid and implying India's journey towards a vaccine is slow. Four nations -- US, UK, China and Russia -- are pressing ahead with vaccination as a new, more infectious mutation of the virus has brought life to a standsti...
-
British Foreign Secretary Calls On PM Modi; Discusses Post-Brexit World
British Foreign Secretary Dominic Raab called on Prime Minister Narendra Modi on Wednesday and discussed the vast potential of the India-UK partnership in the post-Brexit world, and launching of a 'vaccines hub' which will share best practice for clinical trials and foster innovation besides helping in shared fight against coronavirus.
